Related Experiment Video
Updated: Mar 6, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability
Jr-M Yang1, P Schiapparelli2,3, H-N Nguyen1
1Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract:
PTEN is a PIP3 phosphatase that antagonizes oncogenic PI3-kinase signalling. Due to its critical role in suppressing the potent signalling pathway, it is one of the most mutated tumour suppressors, especially in brain tumours. It is generally thought that PTEN deficiencies predominantly result from either loss of expression or enzymatic activity. By analysing PTEN in malignant glioblastoma primary cells derived from 16 of our patients, we report mutations that block localization of PTEN at the plasma membrane and nucleus without affecting lipid phosphatase activity. Cellular and biochemical analyses as well as structural modelling revealed that two mutations disrupt intramolecular interaction of PTEN and open its conformation, enhancing polyubiquitination of PTEN and decreasing protein stability. Moreover, promoting mono-ubiquitination increases protein stability and nuclear localization of mutant PTEN. Thus, our findings provide a molecular mechanism for cancer-associated PTEN defects and may lead to a brain cancer treatment that targets PTEN mono-ubiquitination.
Insights
Mutations in the PTEN tumor suppressor can disrupt its cellular localization and stability without affecting its enzymatic activity, offering new therapeutic targets for brain cancers like glioblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- PTEN (Phosphatase and tensin homolog) is a crucial tumor suppressor that counteracts PI3K/AKT signaling.
- PTEN mutations are frequent in cancers, particularly glioblastoma, often leading to loss of function.
- Current understanding suggests PTEN deficiency stems mainly from reduced expression or enzymatic inactivity.
Purpose of the Study:
- To investigate novel mechanisms of PTEN dysfunction in glioblastoma beyond loss of expression or enzymatic activity.
- To identify specific PTEN mutations affecting its localization and stability.
- To explore therapeutic strategies targeting PTEN regulation in brain tumors.
Main Methods:
- Analysis of PTEN in primary malignant glioblastoma cells from 16 patients.
- Cellular and biochemical assays to assess PTEN localization, lipid phosphatase activity, and ubiquitination.
- Structural modeling to understand the impact of mutations on PTEN conformation.
- Investigation of the effects of mono-ubiquitination on mutant PTEN stability and localization.
Main Results:
- Identified PTEN mutations in glioblastoma that impair plasma membrane and nuclear localization without altering lipid phosphatase activity.
- Demonstrated that two specific mutations disrupt intramolecular PTEN interactions, leading to an open conformation.
- Observed that these mutations enhance PTEN polyubiquitination and decrease protein stability.
- Found that promoting PTEN mono-ubiquitination enhances the stability and nuclear localization of mutant PTEN.
Conclusions:
- Discovered a molecular mechanism for cancer-associated PTEN defects involving impaired localization and stability.
- Established that PTEN mutations can disrupt its conformation and increase susceptibility to degradation.
- Proposed that targeting PTEN mono-ubiquitination represents a potential therapeutic avenue for brain cancers.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...

